This paper was published in the Cochrane Database of Systemic Reviews 2009 Apr 15;(2):CD005019
Study title and authors:
HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
Navaneethan SD, Perkovic V, Johnson DW, Nigwekar SU, Craig JC, Strippoli GF.
Department of Nephrology and Hypertension, Glickman Urological and Kidney institute, Cleveland Clinic, Cleveland, OH 44195, USA. firstname.lastname@example.org
This paper can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/19370615
This paper assessed the effects of statin therapy on kidney transplant recipients. The paper analysed the results of 14 studies with 3,045 participants that compared death rates of patients.
The analysis found that kidney transplant patients that received statins had a 30% increased risk of death compared to patients who did not take statins.